↓ Skip to main content

PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines

Overview of attention for article published in Investigational New Drugs, May 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (77th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

blogs
1 blog
peer_reviews
1 peer review site

Citations

dimensions_citation
56 Dimensions

Readers on

mendeley
71 Mendeley
Title
PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines
Published in
Investigational New Drugs, May 2014
DOI 10.1007/s10637-014-0090-9
Pubmed ID
Authors

Patricia Izetti, Agnes Hautefeuille, Ana Lucia Abujamra, Caroline Brunetto de Farias, Juliana Giacomazzi, Bárbara Alemar, Guido Lenz, Rafael Roesler, Gilberto Schwartsmann, Alessandro Bersch Osvaldt, Pierre Hainaut, Patricia Ashton-Prolla

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 1%
Unknown 70 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 20%
Student > Bachelor 11 15%
Researcher 10 14%
Student > Master 9 13%
Professor > Associate Professor 4 6%
Other 11 15%
Unknown 12 17%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 18 25%
Agricultural and Biological Sciences 15 21%
Medicine and Dentistry 14 20%
Chemistry 4 6%
Social Sciences 2 3%
Other 3 4%
Unknown 15 21%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 December 2016.
All research outputs
#4,713,145
of 22,858,915 outputs
Outputs from Investigational New Drugs
#159
of 1,168 outputs
Outputs of similar age
#46,736
of 226,454 outputs
Outputs of similar age from Investigational New Drugs
#5
of 15 outputs
Altmetric has tracked 22,858,915 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,168 research outputs from this source. They receive a mean Attention Score of 4.7. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,454 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 77% of its contemporaries.
We're also able to compare this research output to 15 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.